Novelix Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Novelix Pharmaceuticals Ltd · Outcome · 12 Nov 2026, 12:52 am
Novelix Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 4,473 (+23.0% YoY | +21.2% QoQ) ■ EBITDA: 212 (+203.4% YoY | +63.5% QoQ) ■ EBITDA Margin (%): 4.7 (+282 bps YoY | +123 bps QoQ) ■ PAT: 156 (+193.2% YoY | +32.6% QoQ) ■ EPS (INR): 0.57 (+16.3% YoY | +16.3% QoQ)
Original exchange filing (PDF)
More announcements from Novelix Pharmaceuticals Ltd
- Submission of Intimation of Corporate office opening. · 18 Nov 2026
- Submission of Supply agreement intimation. · 13 Nov 2026
- Submission of intimation of change in Designation of Director. · 12 Nov 2026
- Attached as per above Subject. · 12 Nov 2026
- Submission of unaudited financial results for the quarter and half year ended September, 2026. · 12 Nov 2026
- Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve unaudited standalone .... · 11 Nov 2026
- Attached · 03 Oct 2026
- Attached · 02 Oct 2026
